JP2022520105A5 - - Google Patents
Info
- Publication number
- JP2022520105A5 JP2022520105A5 JP2021547415A JP2021547415A JP2022520105A5 JP 2022520105 A5 JP2022520105 A5 JP 2022520105A5 JP 2021547415 A JP2021547415 A JP 2021547415A JP 2021547415 A JP2021547415 A JP 2021547415A JP 2022520105 A5 JP2022520105 A5 JP 2022520105A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- composition
- individual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962806604P | 2019-02-15 | 2019-02-15 | |
| US62/806,604 | 2019-02-15 | ||
| US201962925704P | 2019-10-24 | 2019-10-24 | |
| US62/925,704 | 2019-10-24 | ||
| PCT/US2020/018405 WO2020168271A1 (en) | 2019-02-15 | 2020-02-14 | Methods and compositions for treating mast cell gastritis, mast cell esophagitis, mast cell enteritis, mast cell duodenitis, and/or mast cell gastroenteritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022520105A JP2022520105A (ja) | 2022-03-28 |
| JP2022520105A5 true JP2022520105A5 (https=) | 2023-02-22 |
Family
ID=72044142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547415A Pending JP2022520105A (ja) | 2019-02-15 | 2020-02-14 | マスト細胞性胃炎、マスト細胞性食道炎、マスト細胞性腸炎、マスト細胞性十二指腸炎、および／またはマスト細胞性胃腸炎を処置するための方法および組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220135673A1 (https=) |
| EP (1) | EP3923986A4 (https=) |
| JP (1) | JP2022520105A (https=) |
| KR (1) | KR20210126084A (https=) |
| CN (1) | CN113747918A (https=) |
| AU (1) | AU2020223365A1 (https=) |
| BR (1) | BR112021015009A2 (https=) |
| CA (1) | CA3130072A1 (https=) |
| IL (1) | IL285430A (https=) |
| MX (1) | MX2021009626A (https=) |
| SG (1) | SG11202108833QA (https=) |
| WO (1) | WO2020168271A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3618868A4 (en) | 2017-05-05 | 2021-02-24 | Allakos Inc. | METHODS AND COMPOSITIONS FOR TREATING ALLERGIC EYE DISEASES |
| IL270304B2 (en) * | 2017-05-05 | 2024-07-01 | Allakos Inc | Methods and preparations for the treatment of inflammatory disorders in the digestive system |
| WO2021081411A1 (en) * | 2019-10-24 | 2021-04-29 | Allakos Inc. | Methods and compositions for treating irritable bowel syndrome and functional dyspepsia |
| JP2023547621A (ja) * | 2020-10-22 | 2023-11-13 | アラコス インコーポレイテッド | 抗ｓｉｇｌｅｃ－８抗体製剤 |
| CN116963775A (zh) * | 2021-03-03 | 2023-10-27 | 爱乐科斯公司 | 抗siglec-8抗体制剂 |
| IL308258A (en) | 2021-05-05 | 2024-01-01 | Immatics Biotechnologies Gmbh | Bma031 antigen binding polypeptides |
| IL316176A (en) * | 2022-04-22 | 2024-12-01 | Inhibrx Biosciences Inc | SIGLEC-8 binding proteins and their uses |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2465873A1 (en) * | 2010-12-16 | 2012-06-20 | Deutsches Rheuma-Forschungszentrum Berlin | Eosinophils as a therapeutic target |
| NZ720769A (en) * | 2013-12-09 | 2022-10-28 | Allakos Inc | Anti-siglec-8 antibodies and methods of use thereof |
| IL270304B2 (en) * | 2017-05-05 | 2024-07-01 | Allakos Inc | Methods and preparations for the treatment of inflammatory disorders in the digestive system |
-
2020
- 2020-02-14 AU AU2020223365A patent/AU2020223365A1/en active Pending
- 2020-02-14 WO PCT/US2020/018405 patent/WO2020168271A1/en not_active Ceased
- 2020-02-14 BR BR112021015009-9A patent/BR112021015009A2/pt not_active IP Right Cessation
- 2020-02-14 US US17/430,256 patent/US20220135673A1/en not_active Abandoned
- 2020-02-14 KR KR1020217029121A patent/KR20210126084A/ko not_active Ceased
- 2020-02-14 CA CA3130072A patent/CA3130072A1/en active Pending
- 2020-02-14 JP JP2021547415A patent/JP2022520105A/ja active Pending
- 2020-02-14 SG SG11202108833QA patent/SG11202108833QA/en unknown
- 2020-02-14 EP EP20756504.5A patent/EP3923986A4/en not_active Withdrawn
- 2020-02-14 MX MX2021009626A patent/MX2021009626A/es unknown
- 2020-02-14 CN CN202080028635.6A patent/CN113747918A/zh active Pending
-
2021
- 2021-08-08 IL IL285430A patent/IL285430A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022520105A5 (https=) | ||
| JP7579227B2 (ja) | 瘻孔を伴うクローン病の治療用ベドリズマブ | |
| JP7436477B2 (ja) | ＴＧＦ－β受容体融合タンパク質医薬組成物およびその使用 | |
| JP2020518645A5 (https=) | ||
| AU2015237275B2 (en) | Antibodies that bind human cannabinoid 1 (CB1) receptor | |
| US12527784B2 (en) | Combined pharmaceutical composition for treating small cell lung cancer | |
| JP2015509962A5 (https=) | ||
| CN112512580B (zh) | Ezh2抑制剂与免疫检查点抑制剂联合在制备治疗肿瘤的药物中的用途 | |
| JP2022542472A5 (https=) | ||
| CN111886252B (zh) | 促进胰岛细胞生长的方法 | |
| AU2016330471B2 (en) | Antibodies that bind human cannabinoid 1 (CB1) receptor | |
| JP2024534602A5 (https=) | ||
| WO2023061472A1 (zh) | 抗her2抗体药物偶联物和酪氨酸激酶抑制剂联合在制备治疗肿瘤的药物中的用途 | |
| JP2020518638A5 (https=) | ||
| CN112007162B (zh) | Ezh2抑制剂与免疫检查点抑制剂、vegfr抑制剂联合在制备治疗肿瘤药物中的用途 | |
| KR20250136391A (ko) | 병용 요법을 위한 방법 및 조성물 | |
| CA3181598A1 (en) | Combination drug for treating kidney cancer | |
| JP2021523117A5 (https=) | ||
| AU2022321783A1 (en) | Pharmaceutical composition for treating small cell lung cancer | |
| KR20240012472A (ko) | 요로상피암 치료에 있어서 면역관문 억제제와 병용투여되는 항체-약물 접합체의 용도 | |
| JP2022520572A5 (https=) | ||
| CN115279405B (zh) | 一种抗pd-1抗体在制备治疗肢端黑色素瘤的药物中的用途 | |
| JP2022553378A5 (https=) | ||
| TW202034925A (zh) | Ｃｄｋ４／６抑制劑聯合免疫治療在製備治療淋巴瘤的藥物中的用途 | |
| JP2022520572A (ja) | 免疫グロブリン軽鎖に対するモノクローナル抗体と、抗体産生細胞および他の免疫細胞上のｃｄ３８細胞膜分子に対するモノクローナル抗体の組み合わせによるａｌアミロイドーシスの処置 |